Researchers study the link between non-Hodgkin’s lymphoma (NHL) and aging through a variety of approaches that combine clinical data, biological investigations, and population-level analyses. This multifaceted research aims to understand how aging influences the development, progression, and treatment outcomes of…
Non-Hodgkin’s lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is part of the body’s immune system. While the exact causes of NHL are not fully understood, it is known that a combination of genetic,…
Non-Hodgkin’s lymphoma (NHL) is a diverse group of cancers that originate from the lymphatic system, which is part of the immune system. It is characterized by the abnormal growth of lymphocytes, a type of white blood cell. The progression of…
Monoclonal antibodies have become a cornerstone in the treatment of non-Hodgkin’s lymphoma (NHL), offering targeted therapy that specifically attacks cancer cells while sparing much of the healthy tissue. Their effectiveness lies in their ability to recognize and bind to unique…
CAR-T cell therapy has significantly improved survival rates for many patients with non-Hodgkin’s lymphoma (NHL), particularly those with relapsed or refractory disease who have exhausted conventional treatments. This innovative treatment uses genetically engineered T cells that are designed to recognize…
Recent breakthroughs in non-Hodgkin’s lymphoma (NHL) research have significantly advanced understanding and treatment options, particularly for aggressive B-cell lymphomas. One major area of progress involves the detailed study of B-cell receptor (BCR) types, which are crucial for the survival and…
International registries have the potential to harmonize multiple sclerosis (MS) data for cross-country comparisons, but achieving this harmonization involves overcoming significant challenges related to data standardization, interoperability, and methodological consistency. Harmonization means creating a unified framework where data collected from…
The global incidence trends of multiple sclerosis (MS) show a clear relationship with urbanization and lifestyle changes, reflecting a complex interplay of environmental, social, and biological factors. MS, an autoimmune disease affecting the central nervous system, has historically been more…
The quest to expand multiple sclerosis (MS) care globally is a complex challenge that involves addressing several key areas: accessibility, affordability, and innovation. MS is a chronic and unpredictable disease affecting the central nervous system, with symptoms ranging from fatigue…
Multiple sclerosis (MS) presents a complex set of challenges in any context, but these difficulties become uniquely intensified in humanitarian and conflict settings. These environments are marked by instability, limited resources, disrupted healthcare infrastructure, and heightened vulnerability of affected populations,…